Safety alerts
33 safety alerts appeared in Australia during Week 16, 2026. Safety concentration usually matters to quality, vigilance, and post-market surveillance teams because it can reveal emerging field risks.
Australia medical device regulatory intelligence, Week 16, 2026.
Signals from 2026-04-13 to 2026-04-19, covering safety alerts, regulatory changes, device registrations, market movement, and source activity for Australia.
Signals
34
Sources
2
Index status
Indexable
EXECUTIVE SUMMARY
Australia generated 34 qualifying medical device signals during Week 16, 2026. Safety alerts led the week with 33 signals, while FDA Device Enforcement was the most active source. LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs. Philips recalls ALLURA Xper FD20 OR Table due to intermittent X-ray imaging issues with the foot switch.
Key observations
Safety alerts accounted for 33 of 34 qualifying signals, making it the main review lane for the week.
Market signals formed the second-largest cluster, which is useful context for teams separating safety work from regulatory and market monitoring.
FDA Device Enforcement contributed 33 signals, so source-level follow-up should start there.
Burlington appeared repeatedly in the highlighted signals, which may warrant closer product, manufacturer, or competitor tracking.
Category interpretation
Market signals
1 market signals appeared in Australia during Week 16, 2026. Market signals help connect regulatory monitoring with launch planning, reimbursement, and commercial strategy.
Recommended monitoring focus
- Review TGA safety and recall activity for product categories that overlap your portfolio.
- Use market trend signals to brief commercial, strategy, and market access teams alongside regulatory stakeholders.
- Maintain weekly monitoring for Australia, especially when low-volume weeks precede regulator database updates.
- Validate high-impact items against the original source before using them in quality or regulatory decision-making.
- Compare this week with the next completed week to separate one-off noise from sustained category movement.
Source-backed signal evidence
These source-linked items support the weekly analysis above. They are included for verification and follow-up, not as a raw feed export.
PLOS Medicine·Market signals·
Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review
LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: ALLURA Xper FD20 OR Table; System Code: (1) 722015, (2)722023, (3)722035; (PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.)
Philips recalls ALLURA Xper FD20 OR Table due to intermittent X-ray imaging issues with the foot switch.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class I: Purge Cassette, sold within Impella Pump Sets and Individually Packaged. Labeled and distributed in the below configurations and corresponding product codes. 1. Purge Cassette, 5 Pack; Product Code (Abiomed, Inc.)
Abiomed, Inc. recalls Class I Purge Cassettes due to increased risk of purge leaks in Generation 1 models.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Artoura Breast Tissue Expanders Reference Numbers: SDC-100H SDC-110H SDC-120H SDC-130H SDC-135H SDC-140H SDC-150H SDC-155H Smooth High Profile Tissue Expander, 225cc, 300cc, 375cc, 475cc, 500cc, 600 (Mentor Texas, LP.)
Mentor Texas, LP. recalls Class II Artoura Breast Tissue Expanders due to potential blunt needle tips.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Burlington Medical, Protective Sleeves. (Burlington Medical, LLC)
Burlington Medical recalls Class II protective sleeves due to potential lifespan degradation.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Paradigm Insulin Pump (MMT-712, MMT-715) (Medtronic MiniMed, Inc.)
Medtronic MiniMed's Paradigm Insulin Pumps are recalled due to risks of insulin over- and under-delivery affecting patient safety.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: CPX 4 US Breast Tissue Expanders with Suture Tabs Reference Numbers: 354-9113, 3549313, 354-9314 SILTEX Low Height Tissue Expander Style (9100, 450cc), (9300, 450cc), (9300, 550cc) (Mentor Texas, LP.)
Mentor Texas, LP. recalls Class II CPX 4 US Breast Tissue Expanders due to potential blunt needle tips.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Burlington Medical, Kilt Blockers. (Burlington Medical, LLC)
Burlington Medical's Kilt Blockers recalled due to potential lifespan degradation, affecting worldwide distribution.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Burlington Medical, Demi Half Aprons. (Burlington Medical, LLC)
Burlington Medical recalls Class II Demi Half Aprons due to potential attenuation degradation affecting lifespan.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Azurion 5 M12; System Code: (1)722227, (2)722231; (PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.)
Philips recalled Azurion 5 M12 due to intermittent X-ray imaging issues with the wired foot switch.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Atellica CH Enzymatic Hemoglobin A1c (A1c_E); Siemens Material Number (SMN): 11097536; (Siemens Healthcare Diagnostics, Inc.)
Siemens recalls Atellica CH A1c_E due to potential negative bias affecting diabetes diagnosis.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Burlington Medical, Vest (Burlington Medical, LLC)
Burlington Medical recalled its Class II vest due to potential attenuation degradation affecting lifespan.
SourceSafety alerts
FDA Device Enforcement·Safety alerts·
Enforcement Class II: ALLURA Xper FD20 OR Table; System Code: (1) 722015, (2)722023, (3)722035; (PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.)
Philips recalls ALLURA Xper FD20 OR Table due to intermittent X-ray imaging issues with the foot switch.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class I: Purge Cassette, sold within Impella Pump Sets and Individually Packaged. Labeled and distributed in the below configurations and corresponding product codes. 1. Purge Cassette, 5 Pack; Product Code (Abiomed, Inc.)
Abiomed, Inc. recalls Class I Purge Cassettes due to increased risk of purge leaks in Generation 1 models.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Artoura Breast Tissue Expanders Reference Numbers: SDC-100H SDC-110H SDC-120H SDC-130H SDC-135H SDC-140H SDC-150H SDC-155H Smooth High Profile Tissue Expander, 225cc, 300cc, 375cc, 475cc, 500cc, 600 (Mentor Texas, LP.)
Mentor Texas, LP. recalls Class II Artoura Breast Tissue Expanders due to potential blunt needle tips.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Burlington Medical, Protective Sleeves. (Burlington Medical, LLC)
Burlington Medical recalls Class II protective sleeves due to potential lifespan degradation.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Paradigm Insulin Pump (MMT-712, MMT-715) (Medtronic MiniMed, Inc.)
Medtronic MiniMed's Paradigm Insulin Pumps are recalled due to risks of insulin over- and under-delivery affecting patient safety.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: CPX 4 US Breast Tissue Expanders with Suture Tabs Reference Numbers: 354-9113, 3549313, 354-9314 SILTEX Low Height Tissue Expander Style (9100, 450cc), (9300, 450cc), (9300, 550cc) (Mentor Texas, LP.)
Mentor Texas, LP. recalls Class II CPX 4 US Breast Tissue Expanders due to potential blunt needle tips.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Burlington Medical, Kilt Blockers. (Burlington Medical, LLC)
Burlington Medical's Kilt Blockers recalled due to potential lifespan degradation, affecting worldwide distribution.
SourceFDA Device Enforcement·Safety alerts·
Enforcement Class II: Burlington Medical, Demi Half Aprons. (Burlington Medical, LLC)
Burlington Medical recalls Class II Demi Half Aprons due to potential attenuation degradation affecting lifespan.
SourceMarket signals
PLOS Medicine·Market signals·
Rapid diagnostic tests, laboratory-based immunoassay and nucleic acid testing strategies for long-acting injectable pre-exposure prophylaxis: A systematic review
LAI-PrEP testing strategies show similar HIV detection rates but RDTs offer faster results and lower costs.
SourceTrack these signals continuously.
MedFlux monitors regulators and medical device market sources across priority countries so regulatory, quality, and strategy teams can review changes without manually checking agency databases.